MedTrace Logo

Polyamine Treatment in Elderly Patients With Coronary Artery Disease

NCT06186102 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-11-18

No results posted yet for this study

Summary

The present study is testing spermidine treatment in elderly patients with coronary artery disease. The study is a randomized, double-blind, placebo-controlled, two-armed, parallel-group, single centre, clinical study.

Conditions

Interventions

DIETARY_SUPPLEMENT

Spermidine

Spermidine capsule of 8 mg x 3 capsules daily.

OTHER

Placebo

Placebo capsule. 3 capsules daily.

Sponsors & Collaborators

  • Sygesikringen Danmark

    collaborator UNKNOWN

  • Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital

    collaborator UNKNOWN

  • Danish Diabetes Academy

    collaborator OTHER

  • Danish Cardiovascular Academy (DCA)

    collaborator UNKNOWN

  • Eva and Henry Frænkels Mindefond

    collaborator UNKNOWN

  • DoNotAge.org

    collaborator INDUSTRY

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Henrik Wiggers, DMSC PHD MD · Dept. of Cardiology, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-07-31
Completion
2027-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06186102 on ClinicalTrials.gov